<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01195597</url>
  </required_header>
  <id_info>
    <org_study_id>CAT00/10</org_study_id>
    <nct_id>NCT01195597</nct_id>
  </id_info>
  <brief_title>Smoking Cessation and Reduction With an Electronic Nicotine Delivery Device (ENDD)</brief_title>
  <official_title>Effect of an Electronic Nicotine Delivery Device (ENDD) on Smoking Cessation and Reduction: a Pilot Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Universita degli Studi di Catania</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Lega Italiana Anti Fumo</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Arbi Group Srl</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
  </sponsors>
  <source>Universita degli Studi di Catania</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The study's major aim is to investigate the ability of a commercial Electronic Nicotine
      Delivery Device (ENDD) to induce long-term smoking reduction/abstinence in smokers unwilling
      to quit. Secondary aims are to monitor adverse events and measure participants' perception
      and acceptance of the product.

      This pilot study will evaluate smoking reduction/abstinence effects, product preferences, and
      adverse events of a currently marketed device in Italy (&quot;Categoria&quot; electronic cigarette -
      &quot;ORIGINAL&quot; 7.2 mg nicotine cartridges). The primary hypothesis is that the E-Cigarette is a
      safe device that allows smoking reduction or abstinence in smokers.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Cigarette smoking continues to be a very difficult addiction to break. Therefore, improved
      approaches to smoking cessation are necessary. The electronic-cigarette (e-Cigarette), a
      battery-powered electronic nicotine delivery device (ENDD) resembling a cigarette, may help
      smokers to remain abstinent during their quit attempt or to reduce cigarette consumption. The
      efficacy of these devices in smoking cessation and/or smoking reduction studies has never
      been investigated.

      In this prospective proof-of-concept study we monitored possible modifications in smoking
      habits of 40 smokers (unwilling to quit) experimenting the 'Categoria' e-Cigarette focusing
      on smoking reduction and smoking abstinence. Study participants were invited to attend four
      study visits: at baseline, week-4, week-8, and week-12. Product use, number of cigarettes
      smoked, and exhaled carbon monoxide (eCO) levels were measured at each visit. Smoking
      reduction and abstinence rates were calculated. Adverse events and product preferences were
      also reviewed.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>February 2010</start_date>
  <completion_date type="Actual">July 2010</completion_date>
  <primary_completion_date type="Actual">June 2010</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Sustained 50% Reduction in the Number of Cig/Day at Week-24 From Baseline (Reducers)</measure>
    <time_frame>number of cigarettes/day as assessed at week 24</time_frame>
    <description>Participants were monitored for up to 24 weeks. This is the number of smokers who sustained 50% reduction in the number of cig/day at week-24 from baseline (reducers).</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Sustained 80% Reduction in the Number of Cig/Day at Week- 24 From Baseline (Heavy Reducers)</measure>
    <time_frame>number of cigarettes/day as assessed at week 24</time_frame>
    <description>Participants were monitored for up to 24 weeks. This is the number of partecipants who sustained 80% reduction at week 24</description>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Actual">40</enrollment>
  <condition>Nicotine Dependence</condition>
  <condition>Smoking Cessation</condition>
  <arm_group>
    <arm_group_label>E-Cigarette 7.2 mg nicotine</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Well characterized group of 40 regular smokers not intending to quit experimenting the E-Cigarette with 7.2 mg nicotine cartridges.</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>E-Cigarette 7.2 mg nicotine</intervention_name>
    <description>Participants were given a free e-Cigarette kit containing two rechargeable batteries, a charger, and two atomizers and instructed on how to charge, activate and use the e-Cigarette. Key troubleshooting were addressed and phone numbers were supplied for both technical and medical assistance. A full 4-weeks supply of 7.2 mg nicotine cartridges (&quot;Original&quot; cartridges; Arbi Group Srl, Milano, Italy) was also provided and participants were trained on how to load them onto the e-Cigarette's atomizer</description>
    <arm_group_label>E-Cigarette 7.2 mg nicotine</arm_group_label>
    <other_name>E-Cigarette with nicotine cartridges</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  healthy smokers

          -  unwilling to quit

          -  age 18-60 years

          -  smoking ≥ 15 cig/day for at least 5 years

          -  exhaled CO level of ≥ 15 ppm

          -  FTND ≥ 5

        Exclusion Criteria:

          -  alcohol and illicit drug use

          -  breastfeeding or pregnancy

          -  major depression or other psychiatric conditions

          -  previous experience with ENDD

          -  recent myocardial infarction

          -  angina pectoris

          -  high blood pressure (BP&gt;140mm Hg systolic and/or 90mmHg diastolic)

          -  diabetes mellitus

          -  severe allergies

          -  poorly controlled asthma or other airways diseases
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>60 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Riccardo Polosa, MD, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Università di Catania</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Dipartimento di Medicina Interna e Specialistica; Centro per la Prevenzione e Cura del Tabagismo (CPCT)</name>
      <address>
        <city>Catania</city>
        <zip>95124</zip>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Italy</country>
  </location_countries>
  <verification_date>January 2013</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>September 3, 2010</study_first_submitted>
  <study_first_submitted_qc>September 3, 2010</study_first_submitted_qc>
  <study_first_posted type="Estimate">September 6, 2010</study_first_posted>
  <results_first_submitted>May 22, 2012</results_first_submitted>
  <results_first_submitted_qc>August 10, 2012</results_first_submitted_qc>
  <results_first_posted type="Estimate">September 11, 2012</results_first_posted>
  <last_update_submitted>January 3, 2013</last_update_submitted>
  <last_update_submitted_qc>January 3, 2013</last_update_submitted_qc>
  <last_update_posted type="Estimate">January 9, 2013</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Universita degli Studi di Catania</investigator_affiliation>
    <investigator_full_name>Riccardo Polosa</investigator_full_name>
    <investigator_title>Professor of Internal Medicine</investigator_title>
  </responsible_party>
  <keyword>electronic cigarette</keyword>
  <keyword>ENDD</keyword>
  <keyword>nicotine</keyword>
  <keyword>smoking cessation</keyword>
  <keyword>smoking reduction</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Tobacco Use Disorder</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Nicotine</mesh_term>
  </intervention_browse>

  <clinical_results>

    <participant_flow>
      <recruitment_details>Healthy smokers 18-60 years old, smoking ≥ 15 factorymade cigarettes per day (cig/day) for at least the past 10 years and not currently attempting to quit smoking or wishing to do so in the next 30 days were recruited, Italy. None of the participants reported a history of alcohol and drug use, major depression or other psychiatric conditions.</recruitment_details>
      <group_list>
        <group group_id="P1">
          <title>ENDD Group</title>
          <description>Well characterized group of 40 regular smokers not intending to quit experimenting the E-Cigarette with 7.2 mg nicotine cartridges.</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="40"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="27"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="13"/>
              </participants_list>
            </milestone>
          </milestone_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <group_list>
        <group group_id="B1">
          <title>ENDD Group</title>
          <description>Well characterized group of 40 regular smokers not intending to quit experimenting the E-Cigarette with 7.2 mg nicotine cartridges.</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="40"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>&lt;=18 years</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Between 18 and 65 years</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="40"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>&gt;=65 years</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Age</title>
          <units>years</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="42.9" spread="8.8"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Gender</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>Female</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="14"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Male</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="26"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Region of Enrollment</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>Italy</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="40"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Sustained 50% Reduction in the Number of Cig/Day at Week-24 From Baseline (Reducers)</title>
        <description>Participants were monitored for up to 24 weeks. This is the number of smokers who sustained 50% reduction in the number of cig/day at week-24 from baseline (reducers).</description>
        <time_frame>number of cigarettes/day as assessed at week 24</time_frame>
        <population>Intention to treat (ITT)</population>
        <group_list>
          <group group_id="O1">
            <title>Smokers Not Willing to Quit</title>
            <description>7.4 mg nicotine cartridges (&quot;Original&quot; cartridges; Arbi Group Srl, Milano, Italy)</description>
          </group>
        </group_list>
        <measure>
          <title>Sustained 50% Reduction in the Number of Cig/Day at Week-24 From Baseline (Reducers)</title>
          <description>Participants were monitored for up to 24 weeks. This is the number of smokers who sustained 50% reduction in the number of cig/day at week-24 from baseline (reducers).</description>
          <population>Intention to treat (ITT)</population>
          <units>number of participants</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="40"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="13" lower_limit="20" upper_limit="50"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Sustained 80% Reduction in the Number of Cig/Day at Week- 24 From Baseline (Heavy Reducers)</title>
        <description>Participants were monitored for up to 24 weeks. This is the number of partecipants who sustained 80% reduction at week 24</description>
        <time_frame>number of cigarettes/day as assessed at week 24</time_frame>
        <population>Intention to treat (ITT)</population>
        <group_list>
          <group group_id="O1">
            <title>Smokers Not Willing to Quit</title>
            <description>7.4 mg nicotine cartridges (&quot;Original&quot; cartridges; Arbi Group Srl, Milano, Italy)</description>
          </group>
        </group_list>
        <measure>
          <title>Sustained 80% Reduction in the Number of Cig/Day at Week- 24 From Baseline (Heavy Reducers)</title>
          <description>Participants were monitored for up to 24 weeks. This is the number of partecipants who sustained 80% reduction at week 24</description>
          <population>Intention to treat (ITT)</population>
          <units>number of participants</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="40"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="5" lower_limit="25" upper_limit="35"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
    </outcome_list>

    <reported_events>
      <time_frame>6 months</time_frame>
      <desc>daily questionnaire</desc>
      <group_list>
        <group group_id="E1">
          <title>ENDD Group</title>
          <description>Well characterized group of 40 regular smokers not intending to quit experimenting the E-Cigarette with 7.2 mg nicotine cartridges.</description>
        </group>
      </group_list>
      <serious_events>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="40"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>0</frequency_threshold>
        <default_assessment>Systematic Assessment</default_assessment>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="22" subjects_at_risk="40"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Skin and subcutaneous tissue disorders</title>
            <event_list>
              <event>
                <sub_title>troat irritation</sub_title>
                <counts group_id="E1" events="40" subjects_affected="11" subjects_at_risk="40"/>
              </event>
              <event>
                <sub_title>mouth irritation</sub_title>
                <counts group_id="E1" events="40" subjects_affected="11" subjects_at_risk="40"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>Principal Investigators are NOT employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>Prof Riccardo Polosa</name_or_title>
      <organization>University of Catania</organization>
      <phone>0957436413 ext 0039</phone>
      <email>polosa@unict.it, p.caponnetto@unict.it</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

